Skip to content

OCT in Open Fracture and Infected Fracture

Optical Coherence Tomography Imaging to Visualize Bacteria or Biofilm on Hardware, Bone and Soft Tissue in Open Fracture and Infected Fracture

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05785182
Enrollment
40
Registered
2023-03-27
Start date
2023-03-27
Completion date
2027-06-01
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture Infection, Open Fracture, Trauma, Trauma Injury

Brief summary

This is a pilot prospective, observational study of patients with open or infected fracture evaluating the feasibility and acceptability of OCT, a light-based imaging modality that requires no drug or contrast agent.

Interventions

PROCEDUREOpen Fracture

Patients 18 years of age or older with open fracture. Provision of informed consent.

PROCEDUREInfected Fracture

Patients 18 years of age or older with infected fracture. Provision of informed consent.

Sponsors

Dartmouth-Hitchcock Medical Center
Lead SponsorOTHER
Dartmouth College
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Open fracture * Fracture Related Infection

Exclusion criteria

* Metatarsal fractures

Design outcomes

Primary

MeasureTime frameDescription
Feasibility and acceptability of OCT imaging36 monthsThe primary objective of this work is to demonstrate feasibility, acceptability, and preliminary effectiveness of Optical Coherence Tomography (OCT) to image bacteria and biofilm. Data will be analyzed accordingly: The association between optical imaging parameters (particularly around biofilm and bacterial contamination) and (1) surgical wound severity and (2) development of infection or treatment failure for infection.

Countries

United States

Contacts

CONTACTHolly B Symonds
Holly.B.Symonds@hitchcock.org603-653-9440
CONTACTDevin S Mullin
Devin.S.Mullin@hitchcock.org603-650-6032
PRINCIPAL_INVESTIGATORIda L Gitajn

Dartmouth-Hitchcock Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026